Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

Yang Luo; Wei Li; Zefei Jiang; Qingyuan Zhang; Liwei Wang; Yixiang Mao; Vivianne C. G. Tjan-Heijnen; Seock-Ah Im; Robin McConnell; Sara Bejarano; Debora Fumagalli; Jose Bines; Bei Wang; Amit Garg; Whitney P. Kirschbrown; Binghe Xu

doi:10.1097/CAD.0000000000000808

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

Yang Luo, Wei Li, Zefei Jiang, Qingyuan Zhang, Liwei Wang, Yixiang Mao, Vivianne C. G. Tjan-Heijnen, Seock-Ah Im, Robin McConnell, Sara Bejarano, Debora Fumagalli, Jose Bines, Bei Wang, Amit Garg, Whitney P. Kirschbrown^*, Binghe Xu^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	866-872
Number of pages	7
Journal	Anti-Cancer Drugs
Volume	30
Issue number	8
DOIs	https://doi.org/10.1097/CAD.0000000000000808
Publication status	Published - Sep 2019

Keywords

Chinese
early breast cancer
pertuzumab
pharmacokinetics
trastuzumab
DOCETAXEL

Access to Document

10.1097/CAD.0000000000000808

Cite this

Luo, Y., Li, W., Jiang, Z., Zhang, Q., Wang, L., Mao, Y., Tjan-Heijnen, V. C. G., Im, S-A., McConnell, R., Bejarano, S., Fumagalli, D., Bines, J., Wang, B., Garg, A., Kirschbrown, W. P., & Xu, B. (2019). Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. Anti-Cancer Drugs, 30(8), 866-872. https://doi.org/10.1097/CAD.0000000000000808

Luo, Yang ; Li, Wei ; Jiang, Zefei ; Zhang, Qingyuan ; Wang, Liwei ; Mao, Yixiang ; Tjan-Heijnen, Vivianne C. G. ; Im, Seock-Ah ; McConnell, Robin ; Bejarano, Sara ; Fumagalli, Debora ; Bines, Jose ; Wang, Bei ; Garg, Amit ; Kirschbrown, Whitney P. ; Xu, Binghe. / Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. In: Anti-Cancer Drugs. 2019 ; Vol. 30, No. 8. pp. 866-872.

@article{4f4abff061814acba88140ff00826559,

title = "Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer",

keywords = "Chinese, early breast cancer, pertuzumab, pharmacokinetics, trastuzumab, DOCETAXEL",

author = "Yang Luo and Wei Li and Zefei Jiang and Qingyuan Zhang and Liwei Wang and Yixiang Mao and Tjan-Heijnen, {Vivianne C. G.} and Seock-Ah Im and Robin McConnell and Sara Bejarano and Debora Fumagalli and Jose Bines and Bei Wang and Amit Garg and Kirschbrown, {Whitney P.} and Binghe Xu",

year = "2019",

month = sep,

doi = "10.1097/CAD.0000000000000808",

language = "English",

volume = "30",

pages = "866--872",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "8",

}

Luo, Y, Li, W, Jiang, Z, Zhang, Q, Wang, L, Mao, Y, Tjan-Heijnen, VCG, Im, S-A, McConnell, R, Bejarano, S, Fumagalli, D, Bines, J, Wang, B, Garg, A, Kirschbrown, WP & Xu, B 2019, 'Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer', Anti-Cancer Drugs, vol. 30, no. 8, pp. 866-872. https://doi.org/10.1097/CAD.0000000000000808

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. / Luo, Yang; Li, Wei; Jiang, Zefei; Zhang, Qingyuan; Wang, Liwei; Mao, Yixiang; Tjan-Heijnen, Vivianne C. G.; Im, Seock-Ah; McConnell, Robin; Bejarano, Sara; Fumagalli, Debora; Bines, Jose; Wang, Bei; Garg, Amit; Kirschbrown, Whitney P.; Xu, Binghe.

In: Anti-Cancer Drugs, Vol. 30, No. 8, 09.2019, p. 866-872.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

AU - Luo, Yang

AU - Li, Wei

AU - Jiang, Zefei

AU - Zhang, Qingyuan

AU - Wang, Liwei

AU - Mao, Yixiang

AU - Tjan-Heijnen, Vivianne C. G.

AU - Im, Seock-Ah

AU - McConnell, Robin

AU - Bejarano, Sara

AU - Fumagalli, Debora

AU - Bines, Jose

AU - Wang, Bei

AU - Garg, Amit

AU - Kirschbrown, Whitney P.

AU - Xu, Binghe

PY - 2019/9

Y1 - 2019/9

KW - Chinese

KW - early breast cancer

KW - pertuzumab

KW - pharmacokinetics

KW - trastuzumab

KW - DOCETAXEL

U2 - 10.1097/CAD.0000000000000808

DO - 10.1097/CAD.0000000000000808

M3 - Article

VL - 30

SP - 866

EP - 872

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 8

ER -